Early and intermediate term clinical outcome after multiple coronary stenting

Current knowledge on coronary stenting focuses on single-stent procedures. Prior research has shown that single stent deployment yields favorable outcomes in patients with isolated lesions. However, limited data exists on the safety and effectiveness of multiple stent use in complex cases. No prior work had resolved the long-term implications of deploying multiple stents in a single procedure. This gap motivated further investigation into the clinical outcomes of multiple coronary stenting. The need for understanding procedural success rates and event-free survival in this patient group remains unmet. No prior work had resolved the impact of operator experience on procedural outcomes. The absence of comprehensive follow-up data on multiple stent patients highlights a key research need. This paper's contribution lies in its detailed analysis of both immediate and intermediate term outcomes.

This study aimed to evaluate the clinical outcomes of multiple coronary stenting in a consecutive patient cohort. The specific problem addressed was the lack of data on long-term results following the deployment of multiple stents. The motivation stemmed from the increasing use of stents in complex coronary cases. No prior work had resolved the impact of multiple stent use on major clinical events. The study sought to determine procedural success rates and event-free survival. The focus was on patients with unstable coronary syndromes. The goal was to assess the effectiveness of multiple stent deployment in this high-risk group. The study's design allowed for a detailed follow-up of clinical outcomes.

The study used a prospective database to track outcomes in 140 consecutive patients who received multiple stents. Follow-up data was collected via outpatient visits and telephone interviews. Patients were followed for an average of 11.9 months. The study included patients from a tertiary referral center. The primary outcomes measured were death, stroke, MI, CABG, and repeat angioplasty. Data collection included in-hospital and post-discharge events. The number of stents and lesions treated per patient was recorded. The study design allowed for a comprehensive assessment of both procedural and clinical success.

The angiographic success rate was 100%, and the clinical success rate was 93%. Four in-hospital deaths (2.9%) occurred, all in patients with acute MI and shock. Five patients (3.6%) had an MI before discharge. Three late MIs occurred, and one patient required emergency CABG due to stent thrombosis. Eight patients (5.7%) underwent repeat PTCA. Eighty-three patients (61.5%) were asymptomatic at follow-up. One hundred twenty-one patients (86.4%) were free from major events. The mean number of stents per patient was 2.4, and the mean number of lesions treated was 1.4.

The authors propose that multiple coronary stenting can be performed with high procedural success in experienced centers. They suggest that outcomes improve with increased operator experience and optimized deployment techniques. The study indicates that antiplatelet therapy alone may be sufficient in reducing complications. The authors propose that multiple stent use is associated with favorable intermediate-term outcomes. They suggest that most patients remain asymptomatic and event-free at follow-up. The findings suggest that multiple stent procedures are safe in appropriately selected patients. The authors propose that procedural success and event-free survival are achievable with proper technique. They suggest that further research is needed to confirm these findings in larger cohorts.